Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Koenig

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
JAMA Pediatrics|March 1, 2021
Association of Eviction During Pregnancy With Birth Outcomes: An Issue of Health EquityErika G Cordova-Ramos, Robert Koenig, Michael Silverstein
Nature Communications|December 26, 2025
Factoring an integer with three oscillators and a qubitLukas Brenner, Libor Caha, Xavier Coiteux-Roy, et al.
Annals of Internal Medicine|May 16, 2022
Addressing Inequities in SARS-CoV-2 Vaccine Uptake: The Boston Medical Center Health System ExperienceSabrina A Assoumou, Alicia Peterson, Ellen Ginman, et al.
Journal of Medicinal Chemistry|January 29, 2019
Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
Journal of Medicinal Chemistry|March 23, 2019
Correction to Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
ACS Chemical Biology|January 6, 2018
Dual Allosteric Inhibition of SHP2 PhosphataseMichelle Fodor, Edmund Price, Ping Wang, et al.
Journal of Medicinal Chemistry|January 29, 2019
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 InhibitorsPatrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Journal of Medicinal Chemistry|March 23, 2019
Correction to 6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 InhibitorsPatrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Journal of Medicinal Chemistry|September 10, 2020
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
JAMA Pediatrics|March 1, 2021
Association of Eviction During Pregnancy With Birth Outcomes: An Issue of Health EquityErika G Cordova-Ramos, Robert Koenig, Michael Silverstein
Nature Communications|December 26, 2025
Factoring an integer with three oscillators and a qubitLukas Brenner, Libor Caha, Xavier Coiteux-Roy, et al.
Annals of Internal Medicine|May 16, 2022
Addressing Inequities in SARS-CoV-2 Vaccine Uptake: The Boston Medical Center Health System ExperienceSabrina A Assoumou, Alicia Peterson, Ellen Ginman, et al.
Journal of Medicinal Chemistry|January 29, 2019
Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
Journal of Medicinal Chemistry|March 23, 2019
Correction to Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
ACS Chemical Biology|January 6, 2018
Dual Allosteric Inhibition of SHP2 PhosphataseMichelle Fodor, Edmund Price, Ping Wang, et al.
Journal of Medicinal Chemistry|January 29, 2019
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 InhibitorsPatrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Journal of Medicinal Chemistry|March 23, 2019
Correction to 6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 InhibitorsPatrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Journal of Medicinal Chemistry|September 10, 2020
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.
Pageof 5